<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">ZQZkWKtGKFgxcT8qdLYKRVK</article-id>
      <article-id pub-id-type="other">00008</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011001400008</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09700500008</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000103</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Coronariopatia assintom&#225;tica em chag&#225;sicos com insufici&#234;ncia card&#237;aca: preval&#234;ncia e fatores de risco</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>Gustavo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rassi</surname>
            <given-names>Salvador</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bastos</surname>
            <given-names>Jos&#233; Maria Dias de Azeredo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>C&#226;mara</surname>
            <given-names>S&#237;lvio S&#233;rgio Pontes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Goi&#226;nia</named-content>
          <named-content content-type="state">GO</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Goi&#225;s</institution>
        <institution content-type="orgdiv1">Hospital das Cl&#237;nicas </institution>
        <country country="BR">Brasil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>11</month>
        <year>2011</year>
      </pub-date>
      <volume>97</volume>
      <issue>5</issue>
      <fpage>408</fpage>
      <lpage>412</lpage>
      <history>
        <date date-type="rev-recd">
          <day>26</day>
          <month>03</month>
          <year>2011</year>
        </date>
        <date date-type="received">
          <day>20</day>
          <month>02</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>06</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A concomit&#226;ncia de doen&#231;a arterial coron&#225;ria assintom&#225;tica em pacientes com cardiomiopatia chag&#225;sica em IC &#233; controversa na literatura m&#233;dica, pois ambas as doen&#231;as se mostram prevalentes em algumas regi&#245;es do Brasil. Objetivo: Determinar a preval&#234;ncia da coronariopatia (les&#245;es &gt; 50%) em uma popula&#231;&#227;o espec&#237;fica de pacientes com cardiomiopatia chag&#225;sica em IC classes funcionais III e IV, que n&#227;o apresentavam eventos coronarianos pr&#233;vios. OBJETIVO: Determinar a preval&#234;ncia da coronariopatia (les&#245;es &gt; 50%) em uma popula&#231;&#227;o espec&#237;fica de pacientes com cardiomiopatia chag&#225;sica em IC classes funcionais III e IV, que n&#227;o apresentavam eventos coronarianos pr&#233;vios. M&#201;TODOS: Realizou-se cineangiocoronariografia em 61 pacientes consecutivos, portadores de cardiomiopatia chag&#225;sica, em IC classes funcionais III e IV, para se excluir coronariopatia. Esses pacientes faziam parte do protocolo do Estudo de Terapia Celular em Cardiopatias, o qual exigia a realiza&#231;&#227;o de cineangiocoronariografia antes de se injetarem c&#233;lulas-tronco. Os fatores de risco para aterosclerose tamb&#233;m analisados nessa popula&#231;&#227;o foram: idade, hipertens&#227;o arterial, diabetes, dislipidemia, tabagismo e sobrepeso. RESULTADOS: Idade m&#233;dia 51,6 + 9,6 anos, 65,5% (n = 40) homens. A preval&#234;ncia de coronariopatia encontrada nessa popula&#231;&#227;o foi de 1,6% (1). As preval&#234;ncias dos fatores de risco foram: hipertens&#227;o arterial 18% (11), tabagismo 59% (36), diabetes 1,6% (1) e dislipidemia 6,5% (4). CONCLUS&#195;O: A preval&#234;ncia da coronariopatia assintom&#225;tica em pacientes com IC grave de etiologia chag&#225;sica &#233; baixa e, entre os fatores de risco para doen&#231;a coron&#225;ria, o tabagismo foi o mais prevalente.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;a da art&#233;ria coronariana</kwd>
        <kwd>insufici&#234;ncia card&#237;aca</kwd>
        <kwd>doen&#231;a de chagas</kwd>
        <kwd>fatores de risco</kwd>
        <kwd>preval&#234;ncia</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>21</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Coronariopatia assintom&#225;tica em chag&#225;sicos com insufici&#234;ncia card&#237;aca: preval&#234;ncia e fatores de risco</bold>
    </p>
    <p>
      <bold>Gustavo Carvalho; Salvador Rassi; Jos&#233; Maria Dias de Azeredo Bastos; S&#237;lvio S&#233;rgio Pontes C&#226;mara</bold>
    </p>
    <p>Hospital das Cl&#237;nicas da Universidade Federal de Goi&#225;s, Goi&#226;nia, GO, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nota1">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A concomit&#226;ncia de doen&#231;a arterial coron&#225;ria assintom&#225;tica em pacientes com cardiomiopatia chag&#225;sica em IC &#233; controversa na literatura m&#233;dica, pois ambas as doen&#231;as se mostram prevalentes em algumas regi&#245;es do Brasil. Objetivo: Determinar a preval&#234;ncia da coronariopatia (les&#245;es &gt; 50%) em uma popula&#231;&#227;o espec&#237;fica de pacientes com cardiomiopatia chag&#225;sica em IC classes funcionais III e IV, que n&#227;o apresentavam eventos coronarianos pr&#233;vios. </p>
    <p><bold>OBJETIVO:</bold> Determinar a preval&#234;ncia da coronariopatia (les&#245;es &gt; 50%) em uma popula&#231;&#227;o espec&#237;fica de pacientes com cardiomiopatia chag&#225;sica em IC classes funcionais III e IV, que n&#227;o apresentavam eventos coronarianos pr&#233;vios. </p>
    <p><bold>M&#201;TODOS:</bold> Realizou-se cineangiocoronariografia em 61 pacientes consecutivos, portadores de cardiomiopatia chag&#225;sica, em IC classes funcionais III e IV, para se excluir coronariopatia. Esses pacientes faziam parte do protocolo do Estudo de Terapia Celular em Cardiopatias, o qual exigia a realiza&#231;&#227;o de cineangiocoronariografia antes de se injetarem c&#233;lulas-tronco. Os fatores de risco para aterosclerose tamb&#233;m analisados nessa popula&#231;&#227;o foram: idade, hipertens&#227;o arterial, diabetes, dislipidemia, tabagismo e sobrepeso. </p>
    <p><bold>RESULTADOS:</bold> Idade m&#233;dia 51,6 + 9,6 anos, 65,5% (n = 40) homens. A preval&#234;ncia de coronariopatia encontrada nessa popula&#231;&#227;o foi de 1,6% (1). As preval&#234;ncias dos fatores de risco foram: hipertens&#227;o arterial 18% (11), tabagismo 59% (36), diabetes 1,6% (1) e dislipidemia 6,5% (4). </p>
    <p><bold>CONCLUS&#195;O:</bold> A preval&#234;ncia da coronariopatia assintom&#225;tica em pacientes com IC grave de etiologia chag&#225;sica &#233; baixa e, entre os fatores de risco para doen&#231;a coron&#225;ria, o tabagismo foi o mais prevalente.</p>
    <p><bold>Palavras-chave:</bold> Doen&#231;a da art&#233;ria coronariana, insufici&#234;ncia card&#237;aca, doen&#231;a de chagas, fatores de risco, preval&#234;ncia.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>No Brasil, a principal etiologia de insufici&#234;ncia card&#237;aca (IC) &#233; a cardiopatia isqu&#234;mica associada &#224; hipertens&#227;o arterial<sup>1</sup>. No entanto, em regi&#245;es de baixas condi&#231;&#245;es socioecon&#244;micas, a doen&#231;a de Chagas apresenta caracter&#237;sticas end&#234;micas e constitui importante causa de cardiomiopatia dilatada e IC, respons&#225;vel por elevados &#237;ndices de morbimortalidade<sup>1-3</sup>.</p>
    <p>Em pacientes com IC, diagn&#243;stico e tratamento precoces, bem como estratifica&#231;&#227;o progn&#243;stica, s&#227;o muito importantes, no sentido de promover melhora da sobrevida e da qualidade de vida e, algumas vezes, a revers&#227;o total ou parcial do quadro de IC. Nesse contexto, as etiologias chag&#225;sica e isqu&#234;mica s&#227;o importantes marcadores de mau progn&#243;stico<sup>1,4-6</sup>. </p>
    <p>Apesar de muitos pacientes com cardiomiopatia chag&#225;sica terem morte precoce, em virtude de suas complica&#231;&#245;es, o tratamento atual para IC tem melhorado substancialmente a longevidade e a qualidade de vida desses indiv&#237;duos<sup>1</sup>. </p>
    <p>No entanto, &#233; fact&#237;vel considerar a possibilidade de uma sobreposi&#231;&#227;o das etiologias respons&#225;veis por cardiomiopatia cr&#244;nica, principalmente em &#225;reas end&#234;micas de doen&#231;a de Chagas, em que a popula&#231;&#227;o &#233; exposta a fatores de risco para doen&#231;a arterial coron&#225;ria<sup>1</sup>. Vale ressaltar ainda que, nos casos de disfun&#231;&#227;o ventricular esquerda de causa isqu&#234;mica, a fun&#231;&#227;o sist&#243;lica pode ser melhorada ou normalizada, caso os pacientes sejam adequadamente revascularizados<sup>6-8</sup>.</p>
    <p>Dessa forma, em pacientes chag&#225;sicos com IC n&#227;o responsivos ao tratamento cl&#237;nico otimizado, devem-se levar em conta n&#227;o apenas situa&#231;&#245;es como o uso inadequado de medica&#231;&#227;o, tromboembolia pulmonar, infec&#231;&#245;es e arritmias<sup>1</sup>, como tamb&#233;m a coexist&#234;ncia de isquemia mioc&#225;rdica provocada pela doen&#231;a coron&#225;ria<sup>1</sup>. Essa associa&#231;&#227;o pode ser mais delet&#233;ria para a fun&#231;&#227;o ventricular, e seu tratamento espec&#237;fico influenciaria positivamente a sobrevida dos pacientes<sup>6</sup>. </p>
    <p>Mesmo sendo a cineangiocoronariografia o procedimento padr&#227;o-ouro para o diagn&#243;stico de doen&#231;a coron&#225;ria, trata-se de um m&#233;todo diagn&#243;stico invasivo pass&#237;vel de complica&#231;&#245;es, em que a disfun&#231;&#227;o ventricular esquerda e a classe funcional IV s&#227;o preditores de mortalidade<sup>9</sup>. Nesses casos, a utiliza&#231;&#227;o da angiotomografia &#233; um m&#233;todo interessante para o diagn&#243;stico de coronariopatia em pacientes com IC, por se tratar de um exame n&#227;o invasivo, al&#233;m de apresentar elevado valor preditivo negativo<sup>10-13</sup>. Entretanto, sua aplicabilidade ainda &#233; limitada pela baixa disponibilidade e o alto custo<sup>13</sup>.</p>
    <p>A documenta&#231;&#227;o da frequ&#234;ncia de doen&#231;a coron&#225;ria em pacientes chag&#225;sicos com IC grave &#233; importante no sentido de auxiliar, de maneira segura e eficaz, a estratifica&#231;&#227;o cl&#237;nica, o tratamento e o progn&#243;stico dessa patologia<sup>1,10-13</sup>. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica e Pesquisa do Hospital das Cl&#237;nicas da Universidade Federal de Goi&#225;s, tendo como n&#250;mero de registro 01/2010. </p>
    <p>Trata-se de um inqu&#233;rito<sup>14</sup> em que se realizou uma avalia&#231;&#227;o temporal transversal em uma popula&#231;&#227;o de pacientes chag&#225;sicos, em classes funcionais III e IV da NYHA, com disfun&#231;&#227;o sist&#243;lica grave do ventr&#237;culo esquerdo. Essa era uma popula&#231;&#227;o de pacientes participantes do Estudo Multic&#234;ntrico Randomizado de Terapia Celular em Cardiopatias (EMRTCC), nos quais deveria ser realizada a cineangiocoronariografia para afastar a possibilidade de uma coronariopatia (les&#227;o <underline>&gt;</underline> 50%), incluindo-se apenas pacientes chag&#225;sicos puros nesse bra&#231;o do estudo. Os procedimentos foram realizados pela mesma equipe m&#233;dica.</p>
    <p>Foram analisados os prontu&#225;rios dos 61 pacientes adultos com cardiomiopatia chag&#225;sica em insufici&#234;ncia card&#237;aca inclu&#237;dos no EMRTCC. </p>
    <p>Os pacientes inclu&#237;dos tiveram o registro de seu sexo, idade, presen&#231;a de coronariopatia obstrutiva, assim como os fatores de risco para doen&#231;a coron&#225;ria: tabagismo, diabetes, hipertens&#227;o arterial, dislipidemia e sobrepeso.</p>
    <p>A coronariopatia obstrutiva foi considerada presente quando, pela estimativa visual, constatou-se na cineangiocoronariografia obstru&#231;&#227;o maior ou igual a 50% em uma art&#233;ria coron&#225;ria epic&#225;rdica. Embora les&#245;es com menor grau de estenose eventualmente causem angina, estas t&#234;m significado progn&#243;stico menor<sup>7,8</sup>.</p>
    <p>Foram considerados tabagistas apenas os pacientes em uso atual de cigarro, conforme anota&#231;&#227;o nos prontu&#225;rios.</p>
    <p>Os pacientes diab&#233;ticos foram aqueles em uso de insulina ou hipoglicemiantes orais, ou, ainda, aqueles com glicemia de jejum acima de 126mg/dl<sup>15</sup>.</p>
    <p>Hipertensos foram considerados os pacientes em uso de anti-hipertensivos ou aqueles com press&#227;o arterial sist&#243;lica maior ou igual a 140mm de merc&#250;rio e diast&#243;lica de 90mm de merc&#250;rio<sup>16</sup>.</p>
    <p>Sobrepeso foi considerado quando o &#237;ndice de massa corporal (IMC) foi superior a 25kg por m<sup>2</sup> (kg/m<sup>2</sup>)<sup>17</sup>.</p>
    <p>A dislipidemia foi constatada quando os pacientes faziam uso de hipolipemiantes ou quando o colesterol total foi maior que 200 mg/dl<sup>18</sup>.</p>
    <p>A an&#225;lise do coeficiente de preval&#234;ncia (frequ&#234;ncia) de doen&#231;a arterial coron&#225;ria foi determinada atrav&#233;s da f&#243;rmula<sup>14</sup>:</p>
    <p>
      <disp-formula id="form01">
        <graphic xlink:href="1678-4170-abc-97-05-0408-00103-e01.jpg"/></disp-formula>
    </p>
    <p>O teste de Kormogolov-Smirnov foi realizado para a determina&#231;&#227;o da distribui&#231;&#227;o da amostra estudada. Em caso de distribui&#231;&#227;o normal, foram utilizados m&#233;dia e desvio-padr&#227;o; nos casos de curva anormal, foi utilizada a mediana.</p>
    <p>A compara&#231;&#227;o entre as frequ&#234;ncias das vari&#225;veis categ&#243;ricas foi realizada com o teste X<sup>2</sup> (Qui-quadrado) ou o teste "T" da diferen&#231;a de propor&#231;&#245;es. Este &#250;ltimo foi utilizado quando uma das frequ&#234;ncias analisadas foi menor que cinco.</p>
    <p>O teste "T" de Student foi realizado para se compararem as frequ&#234;ncias das vari&#225;veis cont&#237;nuas.</p>
    <p>An&#225;lises de regress&#227;o univariada e multivariada foram realizadas para se determinarem os preditores de doen&#231;a coron&#225;ria.</p>
    <p>As margens de erro para os resultados obtidos foram dadas pela f&#243;rmula do erro padr&#227;o para popula&#231;&#227;o infinita. </p>
    <p>Foi utilizado o software SPSS-15.0, sendo considerados significativos valores de p &lt; 0,05 e intervalo de confian&#231;a de 95%.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Os dados obtidos na amostra de 61 pacientes chag&#225;sicos com IC e distribui&#231;&#227;o normal est&#227;o expostos na <xref ref-type="table" rid="tab1">Tabela 1</xref>.</p>
    <table-wrap id="tab1">
      <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gt01.jpg"/></table-wrap>
    <p>O &#250;nico caso de coronariopatia observado na amostra estudada foi uma les&#227;o de 90% de obstru&#231;&#227;o no ter&#231;o m&#233;dio do ramo circunflexo da art&#233;ria coron&#225;riaesquerda (<xref ref-type="fig" rid="fig1">Figura 1</xref>).</p>
    <fig id="fig1">
      <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gf01.jpg"/></fig>
    <p>A an&#225;lise univariada (regress&#227;o log&#237;stica) das vari&#225;veis em rela&#231;&#227;o &#224; coronariopatia est&#225; demonstrada na <xref ref-type="table" rid="tab2">Tabela 2</xref>.</p>
    <table-wrap id="tab2">
      <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gt02.jpg"/></table-wrap>
    <p>Nesta an&#225;lise, o uso do tabaco foi considerado o &#250;nico preditor de doen&#231;a coron&#225;ria na amostra estudada, com o OR = 5.696, representando maiores chances de 5.000 vezes dos tabagistas desenvolverem coronariopatia. Dessa forma, tal fator de risco para coronariopatia foi analisado na regress&#227;o multivariada, n&#227;o sendo considerado preditor independente, pois, para esta an&#225;lise, foi obtido valor de p = 0,089, n&#227;o sendo estatisticamente significativo.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Este estudo analisou 61 pacientes sem cl&#237;nica de doen&#231;a coron&#225;ria, portadores de cardiomiopatia chag&#225;sica e disfun&#231;&#227;o sist&#243;lica grave do ventr&#237;culo esquerdo, submetidos ao protocolo do estudo para implante de c&#233;lulas tronco intracoron&#225;ria, e apenas um apresentou coronariopatia (1,6%). </p>
    <p>A baixa preval&#234;ncia de doen&#231;a coron&#225;ria nesse grupo espec&#237;fico de pacientes chag&#225;sicos possivelmente se deve ao fato de a idade m&#233;dia dos indiv&#237;duos estudados ser baixa, fato que deve ser levado em conta, uma vez que a idade &#233; fator de risco para eventos cardiovasculares<sup>5</sup>. Al&#233;m disso, a cardiomiopatia chag&#225;sica acomete pessoas mais jovens, em que os fatores de risco ainda n&#227;o atuaram significativamente para o desenvolvimento da doen&#231;a coron&#225;ria<sup>1-5</sup>.</p>
    <p>O fumo foi o fator de risco mais prevalente nessa popula&#231;&#227;o. Considerando-se tabagistas apenas aqueles em uso atual do cigarro, seu consumo foi maior que o encontrado na popula&#231;&#227;o geral [59% <italic>versus</italic> 20,1%;p &lt; 0,001]<sup>19-21</sup>. Vale lembrar que a carga tab&#225;gica n&#227;o foi avaliada.</p>
    <p>Nenhum dos demais fatores de risco analisado foi considerado preditor de coronariopatia (<xref ref-type="table" rid="tab2">Tabela 2</xref>).</p>
    <p>Tanto a hipertens&#227;o arterial quanto o diabetes e a dislipidemia foram pouco prevalentes entre os chag&#225;sicos quando comparados &#224; popula&#231;&#227;o geral<sup>1,16,18,21</sup>.</p>
    <p>Aus&#234;ncia de IMC superior a 25kg/m<sup>2</sup> se deve ao fato de os pacientes estudados apresentarem algum grau de caquexia card&#237;aca, em virtude de IC grave com disfun&#231;&#227;o sist&#243;lica ventricular cr&#244;nica<sup>1</sup>.</p>
    <p>Nesse sentido, as baixas preval&#234;ncias de hipertens&#227;o arterial, do diabetes e da dislipidemia, em associa&#231;&#227;o &#224; baixa faixa et&#225;ria dos indiv&#237;duos chag&#225;sicos deste estudo, favoreceriam esse grupo de pacientes, no sentido de apresentarem baixa preval&#234;ncia de doen&#231;a coron&#225;ria, como j&#225; demonstrado. </p>
    <p>Tanto pacientes com insufici&#234;ncia card&#237;aca de etiologia chag&#225;sica quanto isqu&#234;mica apresentam piores progn&#243;sticos, sendo essas causas consideradas preditores independentes de mortalidade cardiovascular<sup>1,22</sup>. Al&#233;m disso, nos casos em que ocorre a detec&#231;&#227;o precoce de sintomas de insufici&#234;ncia card&#237;aca, a abordagem dos fatores preditores de pior progn&#243;stico, pass&#237;veis de controle, proporciona melhor sobrevida, principalmente quando implementados precocemente t&#233;cnicas terap&#234;uticas espec&#237;ficas e f&#225;rmacos eficazes<sup>23-26</sup>.</p>
    <p>Marin-Neto e cols.<sup>27</sup> apresentaram, em publica&#231;&#227;o recente, que, na cardiomiopatia chag&#225;sica, mesmo na aus&#234;ncia de les&#245;es obstrutivas em art&#233;rias coron&#225;rias epic&#225;rdicas, observam-se &#225;reas de d&#233;ficit de perfus&#227;o, quando avaliadas pela cintilografia com t&#225;lio, e ainda que se trata de &#225;reas com viabilidade<sup>27</sup>. Esse fato foi explicado pelas altera&#231;&#245;es na homeostase plaquet&#225;ria e na microcircula&#231;&#227;o desses pacientes<sup>27-29</sup>. Alguns autores admitem, contudo, que a concomit&#226;ncia da disfun&#231;&#227;o da microcircula&#231;&#227;o dos chag&#225;sicos pode somar-se &#224; obstru&#231;&#227;o coron&#225;ria ateroscler&#243;tica epic&#225;rdica, o que poderia ter efeito sin&#233;rgico, no sentido de piorar a perfus&#227;o mioc&#225;rdica, agravando ainda mais a fun&#231;&#227;o card&#237;aca<sup>27-30</sup>.</p>
    <p>A realiza&#231;&#227;o da cineangiocoronariografia em pacientes assintom&#225;ticos n&#227;o &#233; rotineira e apresenta limita&#231;&#245;es &#224; sua indica&#231;&#227;o<sup>1,31</sup>. A angiografia das art&#233;rias coron&#225;rias &#233; um procedimento invasivo, pass&#237;vel de complica&#231;&#245;es, e a disfun&#231;&#227;o sist&#243;lica do ventr&#237;culo esquerdo &#233; preditor de mortalidade<sup>9</sup>.</p>
    <p>Na literatura, n&#227;o foram encontrados grupos semelhantes de pacientes chag&#225;sicos em que tal procedimento tenha sido realizado para a determina&#231;&#227;o da coronariopatia<sup>22,32</sup>.</p>
    <p>M&#233;todos de diagn&#243;stico n&#227;o invasivos, como, por exemplo, a angiotomografia, apresentam boa acur&#225;cia no diagn&#243;stico de coronariopatia e poderiam ser mais seguros para a popula&#231;&#227;o de chag&#225;sicos deste estudo<sup>10-13</sup>. Entretanto, o acesso a esse m&#233;todo ainda &#233; limitado para a maioria dos pacientes chag&#225;sicos, uma vez que eles dependem do sistema p&#250;blico de sa&#250;de, o qual n&#227;o subsidia a realiza&#231;&#227;o desse exame. Al&#233;m disso, n&#227;o dispomos desse equipamento em nossa institui&#231;&#227;o.</p>
    <p>Mesmo com limita&#231;&#245;es na reprodutibilidade dos resultados das an&#225;lises de regress&#227;o log&#237;stica, principalmente em raz&#227;o da pequena casu&#237;stica do grupo estudado, somente o tabagismo foi um fator de risco de coronariopatia, sem ser considerado preditor independente do desfecho.</p>
    <p>Assim, mesmo sabendo da exist&#234;ncia crescente de coronariopatia na popula&#231;&#227;o geral em envelhecimento, a real preval&#234;ncia da doen&#231;a coron&#225;ria em pacientes assintom&#225;ticos &#233; incerta<sup>18</sup>. Em pacientes chag&#225;sicos com IC grave, desde que n&#227;o existam sinais ou sintomas de insufici&#234;ncia coron&#225;ria, a realiza&#231;&#227;o do cateterismo card&#237;aco para se afastar coronariopatia, diante de um quadro de fal&#234;ncia terap&#234;utica cl&#237;nica, al&#233;m de exp&#244;-los aos riscos de um procedimento invasivo<sup>9</sup>, n&#227;o traria benef&#237;cios adicionais, uma vez que a preval&#234;ncia de doen&#231;a coron&#225;ria nesse grupo espec&#237;fico de indiv&#237;duos parece ser baixa. </p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>O presente estudo demonstrou baixa preval&#234;ncia de coronariopatia obstrutiva no grupo espec&#237;fico de pacientes com cardiomiopatia chag&#225;sica em insufici&#234;ncia card&#237;aca grave, sem sinais ou sintomas de coronariopatia, mesmo estando esses indiv&#237;duos expostos aos fatores de risco para eventos cardiovasculares, em que o tabagismo foi muito prevalente.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Gustavo Carvalho pelo Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade Federal de Goi&#225;s.</p>
    <p>
      <fn id="nota1" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Gustavo Carvalho </p>
        <p> Av. C-208, Qd. 217, Lt.13/16, n&#186; 72, apto.701, Jardim Am&#233;rica </p>
        <p> 74255-070 - Goi&#226;nia, GO, Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="gustavocarvalho@cardiol.br">gustavocarvalho@cardiol.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 20/02/11; revisado recebido em 26/03/11; aceito em 01/06/11.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1.	Bocchi EA, Braga FGM, Ferreira AS, Rohde LEP, Olivaria WA, Almeida DR, et al / Sociedade Brasileira de Cardiologia. III Diretriz Brasileira de insufici&#234;ncia card&#237;aca cr&#244;nica. Arq Bras Cardiol. 2009;93(1supl.1):1-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>III Diretriz Brasileira de insufici&#234;ncia card&#237;aca cr&#244;nica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1</fpage>
          <lpage>71</lpage>
          <issue>1</issue>
          <volume>93</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Braga</surname>
              <given-names>FGM</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Rohde</surname>
              <given-names>LEP</given-names>
            </name>
            <name>
              <surname>Olivaria</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2.	Jannen J, Salvatella R (eds). Estimacion cuantitativa de la enfermidad de Chagas em las Am&#233;ricas. Montevideo: Organizacion Panamericana de La Salud; 2006.</mixed-citation>
        <element-citation publication-type="book">
          <source>Estimacion cuantitativa de la enfermidad de Chagas em las Am&#233;ricas</source>
          <date>
            <year>2006</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Jannen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Salvatella</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3.	Minist&#233;rio da Sa&#250;de. Secretaria de Vigil&#226;ncia em Sa&#250;de. Brazilian Consensus on Chagas disease. Rev Soc Bras Med Trop. 2005;38(supl.3):7-29.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Brazilian Consensus on Chagas disease</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>7</fpage>
          <lpage>29</lpage>
          <volume>38</volume>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4.	Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5(2):167-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incidence and epidemiology of heart failure</article-title>
          <source>Heart Fail Rev</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>167</fpage>
          <lpage>73</lpage>
          <issue>2</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kannel</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5.	Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83(1):356-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An updated coronary risk profile: a statement for health professionals</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>356</fpage>
          <lpage>62</lpage>
          <issue>1</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Odell</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Kannel</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6.	Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1151</fpage>
          <lpage>8</lpage>
          <issue>7</issue>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Allman</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Hachamovitch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Udelson</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7.	Sackett DL, Hayanes RB, Guyatt GH, Tugwell P. Clinical epidemiology, a basic science for clinical medicine. Boston: Little Brown; 1990.p.20.</mixed-citation>
        <element-citation publication-type="book">
          <source>Clinical epidemiology, a basic science for clinical medicine</source>
          <date>
            <year>1990</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Sackett</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Hayanes</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Guyatt</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Tugwell</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8.	Harris PJ, Behar VS, Conley MJ, Harrell FE Jr, Lee KL, Peter RH, et al. The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease. Circulation. 1980;62(2):240-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease</article-title>
          <source>Circulation</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>240</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>62</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Behar</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Conley</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Harrell Jr</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9	Grossman W, Baim DS. Grossman's cardiac catheterization, angiography, and intervention. 6<sup>th</sup> ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2000.p.35-65.</mixed-citation>
        <element-citation publication-type="book">
          <source>Grossman's cardiac catheterization, angiography, and intervention</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>35</fpage>
          <lpage>65</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Grossman</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Baim</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10	Cornily JC, Gilard M, Le Gal G, Pennec PY, Vinsonneau U, Blanc JJ, et al. Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation of cardiomyopathy. Eur J Radiol. 2007;61(1):84-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation of cardiomyopathy</article-title>
          <source>Eur J Radiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>84</fpage>
          <lpage>90</lpage>
          <issue>1</issue>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cornily</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Gilard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Le Gal</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pennec</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Vinsonneau</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11.	Andreini D, Pontone G, Pepi M, Bartorelli AL, Magini A, Quaglia C, et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2007;49(20):2044-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2044</fpage>
          <lpage>50</lpage>
          <issue>20</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Andreini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pontone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pepi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bartorelli</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Magini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Quaglia</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12.	Ghostine S, Caussin C, Habis M, Habib Y, Cl&#233;ment C, Sigal-Cinqualbre A, et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J. 2008;29(17):2133-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2133</fpage>
          <lpage>40</lpage>
          <issue>17</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ghostine</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Caussin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Habis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Habib</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cl&#233;ment</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sigal-Cinqualbre</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13.	Rochitte CE, Pinto IMF, Fernandes JL, Azevedo F&#186; F, Jatene A, Carvalho ACC et al / Sociedade Brasileira de Cardiologia. Diretrizes de resson&#226;ncia e tomografia cardiovascular. Arq Bras Cardiol. 2006;87(3):e79-e85.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diretrizes de resson&#226;ncia e tomografia cardiovascular</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e79</fpage>
          <lpage>e85</lpage>
          <issue>3</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>IMF</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Azevedo F&#186;</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jatene</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>ACC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14.	Rouquayrol ZM. Epidemiologia e sa&#250;de. 4&#170; ed. Rio de Janeiro: Medsi; 1993. p.40-1,p.169-71.</mixed-citation>
        <element-citation publication-type="book">
          <source>Epidemiologia e sa&#250;de</source>
          <date>
            <year>1993</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Rouquayrol</surname>
              <given-names>ZM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15.	Sociedade Brasileira de Diabetes. Consenso brasileiro sobre diabetes 2002: diagn&#243;stico e classifica&#231;&#227;o do diabetes melito e tratamento do diabetes melito do tipo 2. - Rio de Janeiro: Diagraphic; 2003.p.1-19.</mixed-citation>
        <element-citation publication-type="book">
          <source>Consenso brasileiro sobre diabetes 2002: diagn&#243;stico e classifica&#231;&#227;o do diabetes melito e tratamento do diabetes melito do tipo 2</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1</fpage>
          <lpage>19</lpage>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16.	Sociedade Brasileira de Cardiologia / Sociedade Brasileira de Hipertens&#227;o / Sociedade Brasileira de Nefrologia. VI Diretrizes brasileiras de hipertens&#227;o arterial. Arq Bras Cardiol. 2010;95(1supl.1):1-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>VI Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>1</fpage>
          <lpage>51</lpage>
          <issue>1</issue>
          <volume>95</volume>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17.	Gigante DP, Barros FC, Post CLA, Olinto MTA. Preval&#234;ncia de obesidade em adultos e seus fatores de risco. Rev Sa&#250;de P&#250;blica. 1997;31(3):236-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia de obesidade em adultos e seus fatores de risco</article-title>
          <source>Rev Sa&#250;de P&#250;blica</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>236</fpage>
          <lpage>46</lpage>
          <issue>3</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gigante</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Post</surname>
              <given-names>CLA</given-names>
            </name>
            <name>
              <surname>Olinto</surname>
              <given-names>MTA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18.	Sposito A, Caramelli B, Fonseca FAH, Bertolami MC, Afiune Neto A, Souza AJ, et al. / Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose. Departamento de aterosclerose. Arq Bras Cardiol. 2007;88(supl.I):3-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose: Departamento de aterosclerose</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>3</fpage>
          <lpage>12</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sposito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Caramelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>FAH</given-names>
            </name>
            <name>
              <surname>Bertolami</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Afiune Neto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19.	Minist&#233;rio da Sa&#250;de. Controle de tabagismo no Brasil. [Acesso em 2010 nov 25]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://portal.saude.gov.br/portal/arquivos/pdf/Controle%20do%20Tabagismo%20no%20Brasil.pdf">http://portal.saude.gov.br/portal/arquivos/pdf/Controle%20do%20Tabagismo%20no%20Brasil.pdf</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>Controle de tabagismo no Brasil</source>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20.	Minist&#233;rio da Sa&#250;de. Portal da sa&#250;de. [Acesso em 2010 nov 25]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://portal.saude.gov.br/portal/saude/area.cfm?id_area=1446">http://portal.saude.gov.br/portal/saude/area.cfm?id_area=1446</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>Portal da sa&#250;de</source>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21.	Jardim PCBV, Gondim MRP, Monego ET, Moreira HG, Vitorino PVO, Souza WKSB, et al. Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira. Arq Bras Cardiol. 2007;88(4):452-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>452</fpage>
          <lpage>7</lpage>
          <issue>4</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>PCBV</given-names>
            </name>
            <name>
              <surname>Gondim</surname>
              <given-names>MRP</given-names>
            </name>
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Vitorino</surname>
              <given-names>PVO</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>WKSB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22.	Lopes ER, Mesquita PM, Mesquita LFV, Chapadeiro E. Aterosclerose e infarto do mioc&#225;rdio em chag&#225;sicos cr&#244;nicos. Arq Bras Cardiol. 1995;65(2):143-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aterosclerose e infarto do mioc&#225;rdio em chag&#225;sicos cr&#244;nicos</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>143</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>65</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Mesquita</surname>
              <given-names>LFV</given-names>
            </name>
            <name>
              <surname>Chapadeiro</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23.	Rassi S, Barreto ACP, Porto CC, Pereira CR, Cala&#231;a BW, Rassi DC. Sobrevida e fatores progn&#243;sticos na insufici&#234;ncia card&#237;aca sist&#243;lica com inicio recente dos sintomas. Arq Bras Cardiol. 2005;84(4):309-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sobrevida e fatores progn&#243;sticos na insufici&#234;ncia card&#237;aca sist&#243;lica com inicio recente dos sintomas</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>309</fpage>
          <lpage>13</lpage>
          <issue>4</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rassi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>ACP</given-names>
            </name>
            <name>
              <surname>Porto</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cala&#231;a</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24.	Braile DM, Godoy MF. Stem cell therapy: a new perspective for the treatment of ischemic heart failure. Arq Bras Cardiol. 2005;84(5):357-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Stem cell therapy: a new perspective for the treatment of ischemic heart failure</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>357</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Braile</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Godoy</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25.	Vilas-Boas F, Feitosa GS, Soares MB, Mota A, Pinho-Filho JA, Almeida AJ, et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol. 2006;87(2):159-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>159</fpage>
          <lpage>66</lpage>
          <issue>2</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vilas-Boas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Mota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pinho-Filho</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26.	Bocchi EA, Bacal F, Guimar&#227;es G, Mendroni A, Mocelin A, Filho AE, et al. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol. 2010;138(1):94-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>94</fpage>
          <lpage>7</lpage>
          <issue>1</issue>
          <volume>138</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Bacal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mendroni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mocelin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27.	Marin-Neto JA, Cunha-Neto E, Maciel BC, Sim&#245;es MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Pathogenesis of chronic Chagas heart disease</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1109</fpage>
          <lpage>23</lpage>
          <issue>9</issue>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cunha-Neto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maciel</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Sim&#245;es</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28.	Feit A, El-Sherif N, Korostoff S. Chagas' disease masquerading as coronary artery disease. Arch Intern Med. 1983;143(1):144-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Chagas' disease masquerading as coronary artery disease</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>1983</year>
          </date>
          <fpage>144</fpage>
          <lpage>5</lpage>
          <issue>1</issue>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Feit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El-Sherif</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Korostoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29.	Sim&#245;es MV, Ayres EM, Santos JL, Schmidt A, Pintya AO, Maciel BC, et al. Detection of myocardial ischemia in Chagas disease patients with atypic precordial pain by exercise and Holter tests. Arq Bras Cardiol. 1993;60(5):315-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Detection of myocardial ischemia in Chagas disease patients with atypic precordial pain by exercise and Holter tests</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>315</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>60</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sim&#245;es</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Ayres</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pintya</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Maciel</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30.	Arreaza N, Puigbo JJ, Acquatella H, Casal H, Giordano H, Valecillos R, et al. Radionuclide evaluation of left ventricular function in chronic Chagas' cardiomyopathy. J Nucl Med. 1983;24(7):563-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Radionuclide evaluation of left ventricular function in chronic Chagas' cardiomyopathy</article-title>
          <source>J Nucl Med</source>
          <date>
            <year>1983</year>
          </date>
          <fpage>563</fpage>
          <lpage>7</lpage>
          <issue>7</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Arreaza</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Puigbo</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Acquatella</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Casal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Valecillos</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31.	Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina -- summary article: a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41(1):159-68.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA 2002 guideline update for the management of patients with chronic stable angina -- summary article: a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina)</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>159</fpage>
          <lpage>68</lpage>
          <issue>1</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gibbons</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Abrams</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Daley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Deedwania</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32.	Auger S, Storino R, Ordo&#241;ez OI, Urrutia MI, Sanmartino M, Romero D, et al. Emerg&#234;ncias em pacientes com doen&#231;a de Chagas na cidade de Buenos Aires (Argentina). Rev Soc Bras Med Trop. 2002;35(6):609-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Emerg&#234;ncias em pacientes com doen&#231;a de Chagas na cidade de Buenos Aires (Argentina)</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>609</fpage>
          <lpage>16</lpage>
          <issue>6</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Auger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Storino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ordo&#241;ez</surname>
              <given-names>OI</given-names>
            </name>
            <name>
              <surname>Urrutia</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Sanmartino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Asymptomatic coronary artery disease in chagasic patients</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Concomitant asymptomatic coronary artery disease in patients with Chagas cardiomyopathy in heart failure is controversial in the medical literature, as both diseases are prevalent in some regions of Brazil. OBJECTIVE: To determine the prevalence of coronary artery disease (lesions &gt; 50%) in a specific population of patients with Chagas cardiomyopathy in HF functional class III and IV, who had no previous coronary events. METHODS: Coronary angiography was performed in 61 consecutive patients with Chagasic cardiomyopathy, in heart failure functional class III and IV, to exclude coronary artery disease. These patients were part of the Cell Therapy Study in Heart Diseases protocol, which required the coronary angiography to be carried out before stem cells were injected. Risk factors for atherosclerosis also analyzed in this population were: age, arterial hypertension, diabetes, dyslipidemia, smoking and overweight. RESULTS: mean age was 51.6 + 9.6 years and 65.5% (n = 40) of them were males. The prevalence of coronary disease in this population was 1.6% (1). The prevalence of risk factors were: arterial hypertension 18% (11), smoking 59% (36), diabetes 1.6% (1) and dyslipidemia, 6.5% (4). CONCLUSION: The prevalence of asymptomatic coronary artery disease in patients with severe heart failure due to Chagas disease is low and among the risk factors for coronary heart disease, smoking was the most prevalent.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Coronary artery disease/complications</kwd>
        <kwd>heart failure</kwd>
        <kwd>chagas disease</kwd>
        <kwd>risk factors</kwd>
        <kwd>prevalence</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="nota_1-body2">
          <label>
            <bold>Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risk factors</bold>
          </label>
          <p>
            <bold>Gustavo Carvalho; Salvador Rassi; Jos&#233; Maria Dias de Azeredo Bastos; S&#237;lvio S&#233;rgio Pontes C&#226;mara</bold>
          </p>
        </fn>
      </p>
      <p>Hospital das Cl&#237;nicas da Universidade Federal de Goi&#225;s, Goi&#226;nia, GO, Brasil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Concomitant asymptomatic coronary artery disease in patients with Chagas cardiomyopathy in heart failure is controversial in the medical literature, as both diseases are prevalent in some regions of Brazil.</p>
      <p><bold>OBJETIVE:</bold> To determine the prevalence of coronary artery disease (lesions &gt; 50%) in a specific population of patients with Chagas cardiomyopathy in HF functional class III and IV, who had no previous coronary events.</p>
      <p><bold>METHODS:</bold> Coronary angiography was performed in 61 consecutive patients with Chagasic cardiomyopathy, in heart failure functional class III and IV, to exclude coronary artery disease. These patients were part of the Cell Therapy Study in Heart Diseases protocol, which required the coronary angiography to be carried out before stem cells were injected. Risk factors for atherosclerosis also analyzed in this population were: age, arterial hypertension, diabetes, dyslipidemia, smoking and overweight.</p>
      <p><bold>RESULTS:</bold> mean age was 51.6 + 9.6 years and 65.5% (n = 40) of them were males. The prevalence of coronary disease in this population was 1.6% (1). The prevalence of risk factors were: arterial hypertension 18% (11), smoking 59% (36), diabetes 1.6% (1) and dyslipidemia, 6.5% (4).</p>
      <p><bold>CONCLUSION:</bold> The prevalence of asymptomatic coronary artery disease in patients with severe heart failure due to Chagas disease is low and among the risk factors for coronary heart disease, smoking was the most prevalent.</p>
      <p><bold>Keywords:</bold> Coronary artery disease/complications; heart failure; chagas disease; risk factors; prevalence.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>In Brazil, the main etiology of heart failure (HF) is ischemic heart disease associated with arterial hypertension<sup>1</sup>. However, in regions of low socioeconomic status, Chagas' disease has endemic characteristics and is an important cause of dilated cardiomyopathy and HF, accounting for high morbimortality rates<sup>1-3</sup>. </p>
      <p>In patients with HF, early diagnosis and treatment, as well as prognostic stratification, are very important to promote improved survival and quality of life and, sometimes, total or partial reversal of the HF picture. In this context, the ischemic and Chagasic etiologies are important markers of poor prognosis<sup>1,4-6</sup>.</p>
      <p>Although many patients with Chagasic cardiomyopathy have a premature death due to complications, the current treatment for HF has substantially improved longevity and quality of life of these individuals<sup>1</sup>.</p>
      <p>However, it is reasonable to consider the possibility of an overlap of etiologies responsible for chronic cardiomyopathy, mainly in areas of endemic Chagas disease, where the population is exposed to risk factors for coronary artery disease<sup>1</sup>. It is worth mentioning that in cases of left ventricular dysfunction due to ischemia, systolic function may be improved or normalized, if patients are adequately revascularized<sup>6-8</sup>.</p>
      <p>Therefore, in Chagasic patients with HF unresponsive to optimized medical therapy, one should take into account not only situations such as the inappropriate use of medication, pulmonary thromboembolism, infections and arrhythmias<sup>1</sup>, but also the coexistence of myocardial ischemia caused by coronary disease<sup>1</sup>. This association may be more deleterious to the ventricular function and its specific treatment would positively influence patient survival<sup>6</sup>.</p>
      <p>Although the coronary angiography is the gold standard procedure for the diagnosis of coronary disease, it is an invasive diagnostic method capable of causing complications, in which left ventricular dysfunction and functional class IV are predictors of mortality<sup>9</sup>. In such cases, the use of angiotomography is an interesting method for the diagnosis of coronary artery disease in patients with HF, as it is a noninvasive test, in addition to having high negative predictive value<sup>10-13</sup>. However, its applicability is still limited by the low availability and high cost<sup>13</sup>.</p>
      <p>Documentation of coronary disease frequency in Chagasic patients with severe heart failure is important in order to help, in a safe and effective manner, the clinical stratification, treatment and prognosis of this pathology<sup>1,10-13</sup>.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This study was approved by the Ethics and Research Committee of Hospital das Clinicas, Universidade Federal de Goi&#225;s, registration number 01/2010.</p>
      <p>The study is an investigation<sup>14</sup> that performed a cross-temporal assessment in a population of Chagasic patients in functional class NYHA III and IV, with severe left ventricular systolic dysfunction. This was a population of patients participating in the Cell Therapy Multicenter Randomized Study in Heart Disease (EMRTCC), in which a coronary angiography had to be performed to rule out the possibility of coronary artery lesions (&gt; 50%) and that included only pure Chagasic patients in this arm of the study. The procedures were performed by the same medical team.</p>
      <p>The medical records of 61 adult patients with Chagasic cardiomyopathy in heart failure included in the EMRTCC were analyzed. The patients' data included in the study were sex, age, presence of obstructive coronary disease, as well as risk factors for coronary heart disease: smoking, diabetes, arterial hypertension, dyslipidemia and overweight.</p>
      <p>Obstructive coronary artery disease was considered present when, by visual estimate, an obstruction <underline>&gt;</underline> 50% was found in the coronary angiography in an epicardial coronary artery. Although lesions with lower degrees of stenosis can eventually cause angina, these have a lower prognostic significance<sup>7,8</sup>.</p>
      <p>Only patients that currently smoked cigarettes were considered smokers, as recorded in medical files. Diabetic patients were those using insulin or oral hypoglycemic agents, or those whose fasting glucose &gt; 126 mg/dL<sup>15</sup>.</p>
      <p>Hypertensive patients were those using antihypertensive drugs or with systolic blood pressure <underline>&gt;</underline> 140 mmHg and diastolic pressure <underline>&gt;</underline> 90 mmHg<sup>16</sup>. Overweight was considered when the body mass index (BMI) was &gt; 25 kg per m<sup>2</sup> (kg/m<sup>2</sup>)<sup>17</sup>. Dyslipidemia was verified when patients were taking lipid-lowering drugs or when total cholesterol was &gt; 200 mg/dL<sup>18</sup>.</p>
      <p>The analysis of the coefficient of prevalence (frequency) of coronary artery disease was determined by the formula<sup>14</sup>:</p>
      <p>
        <disp-formula id="form01-body2">
          <graphic xlink:href="1678-4170-abc-97-05-0408-00103-e01-en.jpg"/></disp-formula>
      </p>
      <p>The Kolmogorov-Smirnov test was performed to determine the distribution of the studied sample. In case of normal distribution, means and standard deviation were used; in cases of abnormal distribution, the median was used. </p>
      <p>The comparison between frequencies of categorical variables was performed using the X<sup>2</sup> (Chi-square) test or the "T" test of the difference of proportions. The latter was used when one of the analyzed frequencies was &lt; 5. Student's <italic>t</italic> test was performed to compare the frequencies of continuous variables. Univariate and multivariate regression analyses were performed to determine predictors of coronary heart disease.</p>
      <p>The margins of error for the results were given by the formula of standard error for infinite population. </p>
      <p>The software SPSS-15.0 was used for statistical calculations, with a 95% confidence interval and p values &lt; 0.05 being considered significant.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>The data obtained from the sample of 61 Chagasic patients with HF and normal distribution are shown in <xref ref-type="table" rid="tab1-body2">Table 1</xref>.</p>
      <table-wrap id="tab1-body2">
        <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gt01-en.jpg"/></table-wrap>
      <p>The only case of coronary artery disease observed in the studied sample was an obstruction of 90% in the mid-third of the circumflex branch of the left coronary artery (<xref ref-type="fig" rid="fig1-body2">Figure 1</xref>). Univariate analysis (logistic regression) of the variables in relation to coronary artery disease is shown in <xref ref-type="table" rid="tab2-body2">Table 2</xref>. </p>
      <fig id="fig1-body2">
        <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gf01-en.jpg"/></fig>
      <table-wrap id="tab2-body2">
        <graphic xlink:href="1678-4170-abc-97-05-0408-00103-gt02-en.jpg"/></table-wrap>
      <p>In this analysis, tobacco use was considered the only predictor of coronary heart disease in the studied sample, with OR = 5.696, representing a 5,000-fold higher chance of smokers to develop coronary artery disease. Therefore, this risk factor for coronary artery disease was analyzed in the multivariate regression, not being considered an independent predictor, as for this analysis a p value of 0.089 was obtained, which was not statistically significant. </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This study analyzed 61 patients with Chagas cardiomyopathy and severe LV systolic dysfunction, with no clinical signs of coronary disease, submitted to a study protocol for intracoronary stem cell implant, and only one patient had coronary artery disease (1.6%). </p>
      <p>The low prevalence of coronary heart disease in this specific group of patients with Chagas disease is possibly due to the fact that the mean age of the subjects is low, a fact that should be taken into account, as age is a risk factor for cardiovascular events<sup>5</sup>. </p>
      <p>Moreover, Chagasic cardiomyopathy affects younger people, in whom the risk factors have not acted significantly for the development of coronary disease<sup>1-5</sup>.</p>
      <p>Smoking was the most prevalent risk factor in this population. Considering as smokers only those patients currently smoking cigarettes, tobacco use was higher than that found in the general population [59% <italic>versus</italic> 20.1%, p &lt;0.001]<sup>19-21</sup>. It is worth noting that tobacco smoke load was not evaluated. None of the other risk factors analyzed was considered a predictor of coronary heart disease (<xref ref-type="table" rid="tab2-body2">Table 2</xref>).</p>
      <p>Arterial hypertension, as well as diabetes and dyslipidemia were less prevalent among Chagasic patients when compared to the general population<sup>1,16,18,21</sup>.</p>
      <p>No BMI &gt; 25kg/m<sup>2</sup> is due to the fact that the studied patients had some degree of cardiac cachexia, due to severe heart failure chronic ventricular systolic dysfunction<sup>1</sup>. </p>
      <p>In this sense, the low prevalence of arterial hypertension, diabetes and dyslipidemia, in association with the low age range of the Chagasic patients in this study, would favor this group of patients, as shown by the low prevalence of coronary heart disease. </p>
      <p>Patients with heart failure of both Chagasic and ischemic etiologies have poor prognosis, and these causes are considered independent predictors of cardiovascular mortality<sup>1,22</sup>. Moreover, in cases where there is early detection of heart failure symptoms, the approach of the predictors of poor prognosis that can be controlled provides better survival, especially when specific therapeutic techniques and effective drug treatment are promptly implemented<sup>23-26</sup>.</p>
      <p>Marin-Neto et al<sup>27</sup> demonstrated, in a recent publication, that in Chagasic cardiomyopathy, even in the absence of obstructive lesions in epicardial coronary arteries, perfusion deficit areas can be observed when assessed by thallium scintigraphy, and also that these are viable areas<sup>27</sup>. This fact was explained by changes in platelet homeostasis and microcirculation of these patients<sup>27-29</sup>. Some authors admit, however, that the concomitance of the microcirculatory dysfunction of Chagasic patients can add to the epicardial atherosclerotic coronary obstruction, which could have a synergistic effect toward myocardial perfusion worsening, further aggravating cardiac function<sup>27-30</sup>.</p>
      <p>The performance of the coronary angiography in asymptomatic patients is not routine and there are limitations to its indication<sup>1,31</sup>. Coronary artery angiography is an invasive procedure capable of causing complications and left ventricular systolic dysfunction is a predictor of mortality<sup>9</sup>.</p>
      <p>In literature, there are no similar groups of Chagasic patients in whom this procedure has been carried out to determine coronary artery disease<sup>22,32</sup>.</p>
      <p>Non-invasive diagnostic methods, such as the angiotomography, have good accuracy in diagnosing coronary artery disease and could be safer for the population of Chagasic patients in this study<sup>10-13</sup>. However, access to this diagnostic method is still limited for most patients with Chagas' disease, as they must be treated by the public health system, which does not subsidize this examination. Moreover, we do not have this equipment in our institution.</p>
      <p>In spite of the limited reproducibility of the logistic regression analysis results, mainly due to the small sample size, only smoking was a risk factor for coronary artery disease and it was not considered an independent outcome predictor. </p>
      <p>Therefore, even though the increasing presence of coronary disease in the aging general population is known, the real prevalence of coronary disease in asymptomatic patients is uncertain<sup>18</sup>. In Chagasic patients with severe HF, as long as there are no signs or symptoms of coronary insufficiency, cardiac catheterization to rule out coronary artery disease in the presence of clinical treatment failure, in addition to exposing patients to the risks of an invasive procedure<sup>9</sup> not would bring additional benefits, as the prevalence of coronary heart disease in this specific group of individuals appears to be low.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>The present study showed low prevalence of obstructive coronary disease in a specific group of patients with Chagas cardiomyopathy in severe heart failure with no signs or symptoms of coronary disease, even though these individuals were exposed to risk factors for cardiovascular events, in which smoking was very prevalent.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Gustavo Carvalho, from Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade Federal de Goi&#225;s.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
